Ellebrecht Lab

Christoph T. Ellebrecht, MD

Dr. Ellebrecht received his MD from the University of Lübeck, Germany. He subsequently completed a research fellowship in the Payne lab, where he invented the chimeric autoantibody receptor (CAAR) T cell concept and advanced several additional cellular immunotherapy technologies that have been licensed to industry partners. He completed his dermatologic residency at the University of Pennsylvania’s 2+2 Physician Scientist track. When he is not in lab, he can be found reading the New York Times, running half marathons, or hiking with his wife and two Shih Tzu pups.